ESMO 2026: another showtime for China drugs

The ESMO (European Society for Medical Oncology) Congress 2026 will take place in Madrid, Spain, on 23-27 October. As one of the most highly-regarded oncology meetings globally, it attracts pharmaceutical/biotechnology firms all over the world to report updates of their novel drugs each year. Abstracts of these research to be presented were released recently. Using data from Pharmcube, a data provider, we notice quite a few China drugs (in various modalities, small molecule TKIs, BsAbs, ADCs, etc) will have data readouts on various cancer types (NSCLC, BC, GEC etc);